CARE Carter Bankshares Forecast, Technical & Fundamental Analysis

CARE in upward trend: price may jump up because it broke its lower Bollinger Band on August 10, 2026

CARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 34 cases where CARE's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CARE just turned positive on September 04, 2026. Looking at past instances where CARE's MACD turned positive, the stock continued to rise in 26 of 38 cases over the following month. The odds of a continued upward trend are 68%.

Following a +0.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARE advanced for three days, in 217 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 56 cases where CARE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.

The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CARE as a result. In 43 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

CARE moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CARE crossed bearishly below the 50-day moving average on August 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

The Aroon Indicator for CARE entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron SMR rating for this company is 24 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CARE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.341) is normal, around the industry mean (1.365). P/E Ratio (5.383) is within average values for comparable stocks, (24.254). CARE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.682). CARE has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.031). P/S Ratio (3.199) is also within normal values, averaging (3.789).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.